100s of titles, one news app for just $10 a month.
Dive Deeper:
NovaBay Pharmaceuticals: Q1 Earnings Insights
NovaBay Pharmaceuticals (AMEX:NBY) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need…
Spectrum Pharmaceuticals's Earnings Outlook
Spectrum Pharmaceuticals (NASDAQ:SPPI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
Earnings Outlook For Eton Pharmaceuticals
Eton Pharmaceuticals (NASDAQ:ETON) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
X4 Pharmaceuticals's Earnings Outlook
X4 Pharmaceuticals (NASDAQ:XFOR) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
One subscription that gives you access to news from hundreds of sites
Xeris Pharmaceuticals's Earnings Outlook
Xeris Pharmaceuticals (NASDAQ:XERS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to…
Cyclacel Pharmaceuticals's Earnings Outlook
Cyclacel Pharmaceuticals (NASDAQ:CYCC) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to…
Get all your news in one place
Latest Business news:
Poor Countries Face a Mounting Catastrophe Fueled by Inflation and Debt
Before war ravaged Yemen, Walid Al-Ahdal did not worry about feeding his children. At his hometown near the Red Sea,…
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
The 'bots' at heart of Twitter buyout row
San Francisco (AFP) - Elon Musk's pausing of his bid to buy Twitter due to questions over "bots" has put…
Slow wage growth won't stop rate rises
The Australian Bureau of Statistics said its wage price index rose by an annual rate of 2.4 per cent, less…
World’s Richest Family Loses $19 Billion in Walmart Wipeout
The Walton family fortune tumbled almost $19 billion on Tuesday after Walmart Inc. slashed its profit outlook. 
Disney+ Is Open to Advertising, With a Few Big Exceptions
CEO Bob Chapek has reportedly laid down some ground rules for what ads Disney's streaming service will accept.
From analysis to good news, read the world’s best news in one place
Netflix Lays Off 150 Staffers in Cutback After Subscriber Loss
Netflix Inc. said Tuesday it’s laying off about 150 employees, fallout from the surprising drop in customers the streaming company…
Will social media companies crack down on the racist conspiracy theory behind the Buffalo massacre?
The Buffalo, New York, mass shooting that claimed 10 lives Saturday was an event shaped by, and for, internet platforms,…

Earnings Outlook For NovaBay Pharmaceuticals

By Benzinga Insights

NovaBay Pharmaceuticals (AMEX:NBY) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement.

Analysts estimate that NovaBay Pharmaceuticals will report an earnings per share (EPS) of $-0.03.

NovaBay Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed EPS by $0.07, which was followed by a 4.44% drop in the share price the next day.

Here's a look at NovaBay Pharmaceuticals's past performance and the resulting price change:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.05 -0.03 -0.04 -0.04
EPS Actual -0.12 -0.05 -0.04 -0.04
Price Change % -4.44% -6.01% -2.53% -3.03%

Stock Performance

Shares of NovaBay Pharmaceuticals were trading at $0.2002 as of May 10. Over the last 52-week period, shares are down 68.74%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for NovaBay Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.

Dive Deeper:
NovaBay Pharmaceuticals: Q1 Earnings Insights
NovaBay Pharmaceuticals (AMEX:NBY) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need…
Spectrum Pharmaceuticals's Earnings Outlook
Spectrum Pharmaceuticals (NASDAQ:SPPI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
Earnings Outlook For Eton Pharmaceuticals
Eton Pharmaceuticals (NASDAQ:ETON) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
X4 Pharmaceuticals's Earnings Outlook
X4 Pharmaceuticals (NASDAQ:XFOR) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
One subscription that gives you access to news from hundreds of sites
Xeris Pharmaceuticals's Earnings Outlook
Xeris Pharmaceuticals (NASDAQ:XERS) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to…
Cyclacel Pharmaceuticals's Earnings Outlook
Cyclacel Pharmaceuticals (NASDAQ:CYCC) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to…
Get all your news in one place